Investing.com - Third Harmonic Bio (NASDAQ: THRD) reported third quarter EPS of $-0.19, $0.16 better than the analyst estimate of $-0.35. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
Third Harmonic Bio's stock price closed at $5.97. It is down -4.94% in the last 3 months and down -68.61% in the last 12 months.
Third Harmonic Bio saw positive EPS revisions and negative EPS revisions in the last 90 days. See Third Harmonic Bio's stock price’s past reactions to earnings here.
According to InvestingPro, Third Harmonic Bio's Financial Health score is "good performance".
Check out Third Harmonic Bio's recent earnings performance, and Third Harmonic Bio's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar